Questions discussed in this category
Any particular concentration?
Hayashi et al., PMID 22272655
Ekstein et al., PMID 32905614
And what factors push you towards the selection of a specific treatment modality?
Porcine xenografts are no longer available and I am wondering what alternative dressings are other surgeons using.
I worry about introducing skip lesions and there is fairly limited data.
Do you find absorbable sutures more inflammatory?
What factors (cost, erythema, long-term appearance) contribute to your epidermal suture selection?
What surgical and non-surgical techniques have you used in the past?
Do you favor topical treatments or surgical management?
Are there any medications that surgeons like discontinued before their procedure?
If you perform MART-1 staining, what protocol do you follow?
If not, what tumor characteristics prompt you to collect debulking specimens for paraffin or frozen section staining?
Are there specific cases where you would or would not consider early flap division?
2222021744219602191921209214482154613346205481364313068194611485517083159951666616536157201524714423134171334313399132571324312308
Papers discussed in this category
Journal of the American Academy of Dermatology, 2011-07
J Am Acad Dermatol, 2022 Jun 23
Dermatol Surg,
Arch Dermatol, 2010 Jul 19
Journal of the American Academy of Dermatology, 2004-10
Plastic and reconstructive surgery. Global open, 2021 Aug 04
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2019 Oct 21